Document is current
Any future updates will be listed below
-
Authors
Castelletti, Laura
Yeo, Dannel
van Zandwijk, Nico
Rasko, John E. J. http://orcid.org/0000-0003-2975-807X
-
Funding
Funding for this research was provided by:
Cancer Council NSW (RG20-07, PW18-03)
Li Ka Shing Foundation
National Health and Medical Research Council (1177305)
- License Information
-
More Information
Article History
Received: 30 October 2020
Accepted: 31 January 2021
First Online: 15 February 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: LC, DY and NvZ declare that they have no competing interests.JEJR reports advisory roles as chair of Gene Technology Technical Advisory committee, and in the Office of the Gene Technology Regulator, and Australian Government. JEJR also reports honoraria speaker fees or advisory roles for GSK, Takeda, Gilead, Cynata, Pfizer, Spark, Novartis, Celgene, bluebird bio, Shire, Avrobio; stocks in Genea; consultant role for Rarecyte (stocks in lieu) and Imago.
